Frankfurt, Germany

Thomas Martin Wendrich

This inventor holds 1 USPTO granted patent. Top assignee: Genzyme Corporation. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Thomas Martin Wendrich. Retrieved from https://idiyas.com/inventor/thomas-martin-wendrich

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Thomas Martin Wendrich: Innovator in Biochemistry

Introduction

Thomas Martin Wendrich is a notable inventor based in Frankfurt, Germany. He has made significant contributions to the field of biochemistry, particularly through his innovative research and patents.

Latest Patents

Wendrich holds a patent titled "Polypeptide Having Beta-Hexosaminidase Activity, and Polynucleotides Coding for the Same." This patent reflects his expertise in developing biotechnological solutions that have potential applications in medicine and research.

Career Highlights

Wendrich is currently associated with Genzyme Corporation, a leading biotechnology company known for its focus on rare diseases and innovative therapies. His work at Genzyme has allowed him to contribute to groundbreaking advancements in the field.

Collaborations

Throughout his career, Wendrich has collaborated with talented professionals, including Sebastian Rissom and Ava Chattopadhyay. These collaborations have fostered a creative environment that enhances the development of innovative solutions.

Conclusion

Thomas Martin Wendrich is a distinguished inventor whose work in biochemistry continues to impact the scientific community. His patent and collaborations highlight his commitment to advancing the field and improving health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…